RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AngioDynamics Stock

AngioDynamics EBIT 2024

AngioDynamics EBIT

-34.28 M USD

Ticker

ANGO

ISIN

US03475V1017

WKN

A0B9A5

In 2024, AngioDynamics's EBIT was -34.28 M USD, a 63.22% increase from the -21 M USD EBIT recorded in the previous year.

The AngioDynamics EBIT history

YEAREBIT (undefined USD)
2028e-
2027e-0.2
2026e-13.36
2025e-28.97
2024-34.28
2023-21
2022-19.5
2021-15.1
2020-2.5
20195.7
20181.2
201716.3
201613.6
201522.9
201421.4
201320.1
201212
201119.2
201020.9
200916.1
200819.8
2007-1.5
200610.3
20057.7

AngioDynamics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into AngioDynamics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by AngioDynamics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects AngioDynamics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of AngioDynamics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into AngioDynamics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing AngioDynamics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on AngioDynamics’s growth potential.

AngioDynamics Revenue, EBIT and net profit per share

DateAngioDynamics RevenueAngioDynamics EBITAngioDynamics Net Income
2028e395.98 M undefined0 undefined22.6 M undefined
2027e351.04 M undefined-204,000 undefined10.27 M undefined
2026e314.48 M undefined-13.36 M undefined-4.72 M undefined
2025e290.05 M undefined-28.97 M undefined-16.71 M undefined
2024303.91 M undefined-34.28 M undefined-184.35 M undefined
2023338.8 M undefined-21 M undefined-52.4 M undefined
2022316.2 M undefined-19.5 M undefined-26.5 M undefined
2021291 M undefined-15.1 M undefined-31.5 M undefined
2020264.2 M undefined-2.5 M undefined-166.8 M undefined
2019270.6 M undefined5.7 M undefined61.3 M undefined
2018261.7 M undefined1.2 M undefined16.3 M undefined
2017269.8 M undefined16.3 M undefined5 M undefined
2016353.9 M undefined13.6 M undefined-43.6 M undefined
2015356.5 M undefined22.9 M undefined-3.4 M undefined
2014354.4 M undefined21.4 M undefined2.3 M undefined
2013341.9 M undefined20.1 M undefined-1.2 M undefined
2012221.9 M undefined12 M undefined-5.2 M undefined
2011215.8 M undefined19.2 M undefined8.1 M undefined
2010216 M undefined20.9 M undefined12.3 M undefined
2009195.1 M undefined16.1 M undefined9.9 M undefined
2008166.5 M undefined19.8 M undefined10.9 M undefined
2007112.2 M undefined-1.5 M undefined-9.1 M undefined
200678.5 M undefined10.3 M undefined6.9 M undefined
200560.3 M undefined7.7 M undefined4.5 M undefined

AngioDynamics stock margins

The AngioDynamics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AngioDynamics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AngioDynamics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the AngioDynamics's sales revenue. A higher gross margin percentage indicates that the AngioDynamics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the AngioDynamics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the AngioDynamics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the AngioDynamics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the AngioDynamics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the AngioDynamics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

AngioDynamics Margin History

AngioDynamics Gross marginAngioDynamics Profit marginAngioDynamics EBIT marginAngioDynamics Profit margin
2028e50.9 %0 %5.71 %
2027e50.9 %-0.06 %2.93 %
2026e50.9 %-4.25 %-1.5 %
2025e50.9 %-9.99 %-5.76 %
202450.9 %-11.28 %-60.66 %
202351.42 %-6.2 %-15.47 %
202252.4 %-6.17 %-8.38 %
202153.88 %-5.19 %-10.82 %
202056.89 %-0.95 %-63.13 %
201957.65 %2.11 %22.65 %
201854.99 %0.46 %6.23 %
201753.37 %6.04 %1.85 %
201649.25 %3.84 %-12.32 %
201549.31 %6.42 %-0.95 %
201450.85 %6.04 %0.65 %
201349.28 %5.88 %-0.35 %
201256.47 %5.41 %-2.34 %
201158.25 %8.9 %3.75 %
201058.8 %9.68 %5.69 %
200961.56 %8.25 %5.07 %
200861.62 %11.89 %6.55 %
200759 %-1.34 %-8.11 %
200657.96 %13.12 %8.79 %
200555.39 %12.77 %7.46 %

AngioDynamics Aktienanalyse

What does AngioDynamics do?

AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing AngioDynamics's EBIT

AngioDynamics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of AngioDynamics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

AngioDynamics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in AngioDynamics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about AngioDynamics stock

How much did AngioDynamics achieve in EBIT for the current year?

In the current year, AngioDynamics has achieved an EBIT of -34.28 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company AngioDynamics.

How has the EBIT of AngioDynamics developed in recent years?

The EBIT of AngioDynamics has increased by 63.219% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company AngioDynamics?

The EBIT of AngioDynamics is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does AngioDynamics pay?

Over the past 12 months, AngioDynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AngioDynamics is expected to pay a dividend of 0 USD.

What is the dividend yield of AngioDynamics?

The current dividend yield of AngioDynamics is .

When does AngioDynamics pay dividends?

AngioDynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AngioDynamics?

AngioDynamics paid dividends every year for the past 0 years.

What is the dividend of AngioDynamics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AngioDynamics located?

AngioDynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von AngioDynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AngioDynamics from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did AngioDynamics pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of AngioDynamics in the year 2023?

In the year 2023, AngioDynamics distributed 0 USD as dividends.

In which currency does AngioDynamics pay out the dividend?

The dividends of AngioDynamics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AngioDynamics

Our stock analysis for AngioDynamics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AngioDynamics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.